# IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis

> **NCT04697407** · NA · COMPLETED · sponsor: **Rennes University Hospital** · enrollment: 95 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Blood sampling
- **BIOLOGICAL:** CSF sampling

## Key facts

- **NCT ID:** NCT04697407
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2023-05-23
- **Final completion:** 2023-05-23
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2023-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04697407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04697407, "IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04697407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*